[go: up one dir, main page]

ATE223711T1 - Tts enthaltend ein antioxidans - Google Patents

Tts enthaltend ein antioxidans

Info

Publication number
ATE223711T1
ATE223711T1 AT99902525T AT99902525T ATE223711T1 AT E223711 T1 ATE223711 T1 AT E223711T1 AT 99902525 T AT99902525 T AT 99902525T AT 99902525 T AT99902525 T AT 99902525T AT E223711 T1 ATE223711 T1 AT E223711T1
Authority
AT
Austria
Prior art keywords
antioxidant
ethyl
tts
contain
tts contain
Prior art date
Application number
AT99902525T
Other languages
English (en)
Inventor
Bodo Asmussen
Michael Horstmann
Kai Koepke
Harry Tiemessen
Original Assignee
Novartis Erfind Verwalt Gmbh
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10825116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE223711(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Erfind Verwalt Gmbh, Lohmann Therapie Syst Lts filed Critical Novartis Erfind Verwalt Gmbh
Application granted granted Critical
Publication of ATE223711T1 publication Critical patent/ATE223711T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT99902525T 1998-01-12 1999-01-08 Tts enthaltend ein antioxidans ATE223711T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9800526.7A GB9800526D0 (en) 1998-01-12 1998-01-12 Organic compounds
PCT/EP1999/000078 WO1999034782A1 (en) 1998-01-12 1999-01-08 Tts containing an antioxidant

Publications (1)

Publication Number Publication Date
ATE223711T1 true ATE223711T1 (de) 2002-09-15

Family

ID=10825116

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99902525T ATE223711T1 (de) 1998-01-12 1999-01-08 Tts enthaltend ein antioxidans

Country Status (25)

Country Link
US (1) US6335031B1 (de)
EP (1) EP1047409B1 (de)
KR (1) KR100569051B1 (de)
CN (1) CN1129427C (de)
AT (1) ATE223711T1 (de)
AU (1) AU745661B2 (de)
BR (1) BR9906920A (de)
CA (1) CA2315784C (de)
CZ (1) CZ300598B6 (de)
DE (1) DE69902875T2 (de)
DK (1) DK1047409T3 (de)
ES (1) ES2184408T3 (de)
GB (1) GB9800526D0 (de)
HU (1) HU227159B1 (de)
ID (1) ID27503A (de)
IL (1) IL137100A (de)
MX (1) MXPA00006438A (de)
NO (1) NO328390B1 (de)
NZ (1) NZ505650A (de)
PL (1) PL201328B1 (de)
PT (1) PT1047409E (de)
RU (1) RU2219926C2 (de)
SK (1) SK284622B6 (de)
TR (2) TR200101021T2 (de)
WO (1) WO1999034782A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE286725T1 (de) 1998-10-01 2005-01-15 Novartis Pharma Gmbh Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
FR2793689B1 (fr) * 1999-05-19 2001-08-24 Pf Medicament Dispositif transdermique pour l'administration de testosterone ou d'un de ses derives
PL198323B1 (pl) * 1999-11-29 2008-06-30 Lohmann Therapie Syst Lts Transdermalny system terapeutyczny zawierający wrażliwe na utlenianie substancje czynne i sposób jego wytwarzania
DE10107663B4 (de) * 2001-02-19 2004-09-09 Lts Lohmann Therapie-Systeme Ag Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
FR2881653A1 (fr) * 2005-02-04 2006-08-11 Frederic Khodja Dispositif permettant l'administration en continu d'une dose physiologique controlee d'au moins un mineral ou une vitamine
TWI389709B (zh) 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2009022345A1 (en) * 2007-08-14 2009-02-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Phenyl carbamates for the treatment of multiple sclerosis
ES2669592T3 (es) * 2008-07-28 2018-05-28 Takeda Pharmaceutical Company Limited Composición farmacéutica
US20100087768A1 (en) * 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
MX350357B (es) 2009-12-22 2017-09-05 Luye Pharma Ag Sistema terapeutico transdermico para administrar rivastigmina o derivados de este.
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
ES2363395B1 (es) * 2010-01-20 2012-02-23 Farmalider, S.A. Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral.
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
DE102010026903A1 (de) 2010-07-12 2012-01-12 Amw Gmbh Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff
EP2596071B1 (de) 2010-07-21 2019-02-13 3M Innovative Properties Company Transdermale klebstoffzusammensetzungen, vorrichtungen und verfahren
DK2468274T3 (en) 2010-12-14 2015-08-31 Acino Ag Transdermal therapeutic system for administration of an active substance
KR101788802B1 (ko) * 2010-12-24 2017-10-20 주식회사 삼양바이오팜 리바스티그민을 함유하는 경피흡수제제
KR20120126898A (ko) * 2011-05-13 2012-11-21 에스케이케미칼주식회사 리바스티그민 또는 이의 염을 함유하는 경피 투여 조성물
KR20120130073A (ko) * 2011-05-20 2012-11-28 에스케이케미칼주식회사 리바스티그민 함유 패취
EP2711002A4 (de) 2011-05-20 2014-10-29 Sk Chemicals Co Ltd Pflaster mit rivastigmin
EP2594261A1 (de) 2011-11-18 2013-05-22 Labtec GmbH Zusammensetzung zur transdermalen Verabreichung von Rivastigmin
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
WO2013142339A1 (en) 2012-03-23 2013-09-26 Novartis Ag Transdermal therapeutic system and method
WO2013187451A1 (ja) 2012-06-12 2013-12-19 株式会社 ケイ・エム トランスダーム 貼付剤
WO2014034939A1 (ja) * 2012-09-03 2014-03-06 ニプロパッチ株式会社 貼付剤
KR20140038237A (ko) * 2012-09-20 2014-03-28 에스케이케미칼주식회사 리바스티그민의 안정성이 개선된 의약품
WO2014051128A1 (ja) 2012-09-28 2014-04-03 株式会社 ケイ・エム トランスダーム 貼付剤
WO2014111790A2 (en) 2013-01-15 2014-07-24 Zydus Technologies Limited Stable transdermal pharmaceutical drug delivery system comprising rivastigmine
CN106413695B (zh) * 2014-04-08 2019-12-10 帝国制药美国公司 利伐斯的明透皮组合物及其使用方法
US10308408B2 (en) 2014-05-15 2019-06-04 Nichiban Co., Ltd. Packaging for adhesive patch containing rivastigmine
KR102710072B1 (ko) 2018-08-31 2024-09-24 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
KR102823139B1 (ko) 2018-08-31 2025-06-19 에스케이케미칼 주식회사 장기 투여용 리바스티그민 패취
WO2021166987A1 (ja) * 2020-02-19 2021-08-26 大日本住友製薬株式会社 経皮吸収製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201906B (en) * 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
GB9213322D0 (en) * 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
AU5716898A (en) * 1997-01-08 1998-08-03 Warner-Lambert Company Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
AU5495398A (en) * 1997-01-17 1998-08-07 Takeda Chemical Industries Ltd. Idebenone containing combination agent for treating alzheimer's disease

Also Published As

Publication number Publication date
EP1047409A1 (de) 2000-11-02
ES2184408T3 (es) 2003-04-01
PT1047409E (pt) 2002-12-31
TR200101021T2 (tr) 2002-06-21
SK284622B6 (sk) 2005-08-04
KR20010033072A (ko) 2001-04-25
NO328390B1 (no) 2010-02-08
IL137100A0 (en) 2001-06-14
AU2278599A (en) 1999-07-26
SK10532000A3 (sk) 2000-11-07
TR200001688T2 (tr) 2000-11-21
PL341347A1 (en) 2001-04-09
GB9800526D0 (en) 1998-03-11
DK1047409T3 (da) 2002-12-30
BR9906920A (pt) 2000-10-10
KR100569051B1 (ko) 2006-04-10
HK1034036A1 (en) 2001-10-12
MXPA00006438A (es) 2003-07-21
CA2315784A1 (en) 1999-07-15
CZ20002557A3 (cs) 2000-10-11
HUP0004300A2 (hu) 2001-05-28
US6335031B1 (en) 2002-01-01
RU2219926C2 (ru) 2003-12-27
ID27503A (id) 2001-04-12
CZ300598B6 (cs) 2009-06-24
WO1999034782A1 (en) 1999-07-15
JP3820103B2 (ja) 2006-09-13
CN1288375A (zh) 2001-03-21
PL201328B1 (pl) 2009-03-31
AU745661B2 (en) 2002-03-28
NO20003472L (no) 2000-08-07
DE69902875T2 (de) 2003-05-22
HUP0004300A3 (en) 2003-05-28
HU227159B1 (en) 2010-09-28
CN1129427C (zh) 2003-12-03
JP2002500178A (ja) 2002-01-08
NZ505650A (en) 2002-10-25
IL137100A (en) 2004-12-15
CA2315784C (en) 2006-06-27
DE69902875D1 (de) 2002-10-17
NO20003472D0 (no) 2000-07-05
EP1047409B1 (de) 2002-09-11

Similar Documents

Publication Publication Date Title
ATE223711T1 (de) Tts enthaltend ein antioxidans
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
PT1061900E (pt) Composicoes e metodos para libertacao de uma droga
ATE383849T1 (de) Transdermale pharmazeutische zusammensetzung
TR199802108T2 (xx) �bandronat i�eren oral farmas�tik bir form�lasyon.
AR037081A1 (es) Composicion para el suministro transdermico de fentanilo
TR200502189T1 (tr) Kompozisyonlar ve farmakolojik etken maddelerin aktarımı için yöntemler.
BR9405798A (pt) Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
ATE249422T1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
MA25681A1 (fr) Systeme d'administration de compositions orales de soins comprenant une resine d'organosiloxane utilisant une bandelette de soutien amovible.
BR0107869A (pt) Composições farmacêuticas eletrogiradas
BR0109150A (pt) Método para administração de um anestésico local a um indivìduo em necessidade de um efeito anestésico local, emplastro, composição, e, recipiente
IL179718A0 (en) Pharmaceutical composition containing irbesartan
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
DE60019334D1 (de) Antivirale arznei
PL1608346T3 (pl) Kompozycje dostarczające lek zawierające estry alfa-hydroksykwasów i sposób ich zastosowania
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
EP1300143A4 (de) Pflaster mit 4-biphenylessigsäure
TR200400241T4 (tr) Lasofoksifen'in transdermal olarak verilmesi
HRP20080178T3 (hr) Farmaceutski pripravak u obliku hidrogela za transdermalnu primjenu aktivnih tvari
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
DK0768896T3 (da) Lavdoserede steroidtabletter, der indeholder gallussyreestere som antioxidant, fremgangsmåde til fremstilling og anvendelse
ATE102934T1 (de) Fluorierte flavon-essigsaeure.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification